These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16150368)

  • 1. The importance of clearly defining the perspective of CAM research.
    van Haselen R
    Complement Ther Med; 2005 Sep; 13(3):153-4. PubMed ID: 16150368
    [No Abstract]   [Full Text] [Related]  

  • 2. n-of-1 trials and their combination: suitable approaches for CAM research?
    Hart A; Sutton CJ
    Complement Ther Med; 2003 Dec; 11(4):213-4. PubMed ID: 14969791
    [No Abstract]   [Full Text] [Related]  

  • 3. Does complementary and alternative medicine represent only placebo therapies?
    Bland J
    Altern Ther Health Med; 2008; 14(2):16-8. PubMed ID: 18383985
    [No Abstract]   [Full Text] [Related]  

  • 4. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
    Efficace F; Horneber M; Lejeune S; Van Dam F; Leering S; Rottmann M; Aaronson NK
    J Clin Epidemiol; 2006 Dec; 59(12):1257-65. PubMed ID: 17098568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebuttal paper to 'Sunflower therapy for children with specific learning difficulties (dyslexia): a randomised, controlled trial'.
    Mathews MO; Thomas E; Yeung A
    Complement Ther Clin Pract; 2009 Feb; 15(1):44-6. PubMed ID: 19161955
    [No Abstract]   [Full Text] [Related]  

  • 6. Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT.
    Verhoef MJ; Lewith G; Ritenbaugh C; Boon H; Fleishman S; Leis A
    Complement Ther Med; 2005 Sep; 13(3):206-12. PubMed ID: 16150375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trials as evidence in legal disputes about the benefits of complementary and alternative medicine.
    Coulter ID; Walsh J
    Altern Ther Health Med; 2008; 14(2):60-4. PubMed ID: 18383991
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenges of randomized trials in integrative cancer care.
    Block KI; Cohen AJ; Dobs AS; Ornish D; Tripathy D
    Integr Cancer Ther; 2004 Jun; 3(2):112-27. PubMed ID: 15165498
    [No Abstract]   [Full Text] [Related]  

  • 9. Complementary and alternative therapies: the power of randomization.
    Wild R
    J Soc Gynecol Investig; 2006 Jan; 13(1):1. PubMed ID: 16378909
    [No Abstract]   [Full Text] [Related]  

  • 10. Unconventional therapies and cancer.
    Bégin M; Kaegi E
    CMAJ; 1999 Sep; 161(6):686-7. PubMed ID: 10513271
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo: art or science?
    Rankin-Box D
    Complement Ther Clin Pract; 2008 Aug; 14(3):149-51. PubMed ID: 18640625
    [No Abstract]   [Full Text] [Related]  

  • 12. Marketing studies and scientific research must be distinct.
    Ernst E
    BMJ; 2001 May; 322(7296):1249. PubMed ID: 11388189
    [No Abstract]   [Full Text] [Related]  

  • 13. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The placebo effect.
    Watson R
    J Clin Nurs; 2006 May; 15(5):519. PubMed ID: 16629958
    [No Abstract]   [Full Text] [Related]  

  • 15. Questions about questions.
    Spaight BM
    J Altern Complement Med; 2006 Apr; 12(3):235-6. PubMed ID: 16729413
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to Klassen et al: Missing data should be more heartily penalized.
    Berger VW
    J Clin Epidemiol; 2006 Jul; 59(7):759-60. PubMed ID: 16765281
    [No Abstract]   [Full Text] [Related]  

  • 17. Whatever happened to plausibility as the basis for clinical research and practice after EBM and CAM rushed in?
    Sampson W
    MedGenMed; 2007 Jan; 9(1):19. PubMed ID: 17435626
    [No Abstract]   [Full Text] [Related]  

  • 18. [From medical research to health policy: the case of complementary and alternative medicine].
    Keshet Y
    Harefuah; 2006 Jun; 145(6):446-50, 469. PubMed ID: 16838902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complementary and alternative medicine in the care of patients with breast cancer: report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004.
    Baum M; Ernst E; Lejeune S; Horneber M
    Eur J Cancer; 2006 Aug; 42(12):1702-10. PubMed ID: 16790340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical factors for credibility in clinical trials: Comments on Aickin's "Beyond randomization".
    Walach H
    J Altern Complement Med; 2002 Dec; 8(6):773-5. PubMed ID: 12614530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.